| |
| |
|
| Insider
Information: |
Dansey Roger D |
| Relationship: |
Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,749 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,898 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,749 |
|
|
| Total
Value |
$3,898 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -29.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2018-06-15 |
0 |
Premium* |
|
|
Inovio Biomedical Corp |
INO |
Director |
2024-05-15 |
6,749 |
2022-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2021-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
17,172 |
89,950 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-02-02 |
4 |
AS |
$138.52 |
$108,461 |
D/D |
(783) |
96,853 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-02-15 |
4 |
AS |
$138.62 |
$1,406,395 |
D/D |
(10,000) |
96,853 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-03-15 |
4 |
AS |
$199.81 |
$1,998,115 |
D/D |
(10,000) |
96,853 |
0 |
% |
|
| SGEN |
Seagen Inc |
Interim CEO & CMO |
• – – |
2022-08-31 |
4 |
AS |
$154.41 |
$775,006 |
D/D |
(5,019) |
97,539 |
0 |
% |
|
| SGEN |
Seagen Inc |
Interim CEO & CMO |
• – – |
2022-10-17 |
4 |
AS |
$135.00 |
$1,350,000 |
D/D |
(10,000) |
97,539 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, Research and Develo |
• – – |
2022-12-14 |
4 |
AS |
$135.00 |
$1,350,000 |
D/D |
(10,000) |
97,539 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-01-24 |
4 |
AS |
$135.00 |
$1,350,000 |
D/D |
(10,000) |
97,539 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,660 |
98,513 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-06 |
4 |
AS |
$205.86 |
$68,550 |
D/D |
(333) |
99,389 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-17 |
4 |
AS |
$205.95 |
$2,059,488 |
D/D |
(10,000) |
99,389 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
609 |
99,722 |
0 |
- |
|
| SGEN |
Seagen Inc |
Interim CEO & CMO |
• – – |
2022-10-17 |
4 |
OE |
$65.11 |
$745,421 |
D/D |
10,000 |
99,743 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
AS |
$114.07 |
$228,140 |
D/D |
(2,000) |
101,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
Interim CEO & CMO |
• – – |
2022-08-16 |
4 |
AS |
$170.22 |
$724,095 |
D/D |
(4,254) |
102,558 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2019-09-25 |
4 |
AS |
$73.72 |
$221,415 |
D/D |
(3,000) |
103,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2019-11-18 |
4 |
S |
$116.00 |
$580,000 |
D/D |
(5,000) |
103,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2019-11-25 |
4 |
S |
$121.48 |
$607,388 |
D/D |
(5,000) |
103,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,320 |
104,702 |
0 |
- |
|
| SGEN |
Seagen Inc |
See Remarks |
• – – |
2019-09-03 |
4 |
AS |
$70.80 |
$65,277 |
D/D |
(922) |
106,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
Interim CEO & CMO |
• – – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
44,625 |
106,812 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-02-15 |
4 |
OE |
$72.64 |
$726,400 |
D/D |
10,000 |
106,853 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-03-15 |
4 |
OE |
$72.64 |
$726,400 |
D/D |
10,000 |
106,853 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, Research and Develo |
• – – |
2022-12-14 |
4 |
OE |
$72.64 |
$771,628 |
D/D |
10,000 |
106,942 |
0 |
- |
|
| SGEN |
Seagen Inc |
See Remarks |
• – – |
2019-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
29,475 |
107,068 |
0 |
- |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
